4//SEC Filing
Cambrian BioPharma Inc 4
Accession 0001209191-23-042076
CIK 0001829802other
Filed
Jul 11, 8:00 PM ET
Accepted
Jul 12, 4:27 PM ET
Size
8.5 KB
Accession
0001209191-23-042076
Insider Transaction Report
Form 4
Cambrian BioPharma Inc
10% Owner
Transactions
- Award
Common Stock
2023-07-10+4,466→ 5,240,422 total - Award
Stock Option (Right to Buy)
2023-07-10+14,550→ 14,550 totalExercise: $1.22Exp: 2033-07-09→ Common Stock (14,550 underlying)
Footnotes (3)
- [F1]These shares represent restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of the common stock of the Issuer. The shares underlying the RSUs vest in full on the first anniversary of the date of grant, or July 10, 2024, subject to the James Peyer's continuous service with the Issuer through such vesting date.
- [F2]These shares are held by Cambrian Biopharma, Inc., a Delaware corporation ("Cambrian"). The Chief Executive Officer of Cambrian, James Peyer, may direct the voting and disposition of the shares held by Cambrian, subject in certain instances to the approval of Cambrian's Board of Directors. Mr. Peyer disclaims beneficial ownership of such shares.
- [F3]The shares subject to the option vest and become exercisable in 12 equal monthly installments over a one year period such that the option is fully vested on the first anniversary of the date of grant, or July 10, 2024, subject to James Peyer's continuous service with the Issuer as of each such vesting date; provided that the option will in any case be fully vested on the date of the Company's next annual stockholder meeting, subject to James Peyer's continuous service with the Issuer through such vesting date.
Documents
Issuer
Sensei Biotherapeutics, Inc.
CIK 0001829802
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001797409
Filing Metadata
- Form type
- 4
- Filed
- Jul 11, 8:00 PM ET
- Accepted
- Jul 12, 4:27 PM ET
- Size
- 8.5 KB